Abstract
Radical surgery with extended lymph-node dissection is the treatment of first choice and the only curative treatment for locally advanced gastric cancer. While recent combination chemotherapy with S-1 (a combination of tegafur with two biomodulators, gimeracil and oteracil) has achieved high response rates, controversy still remains regarding the significance of adjuvant cancer chemotherapy after surgery. We have been applying chemosensitivity testing in evaluating the appropriate adjuvant cancer chemotherapy for advanced gastric cancer. Our multiple studies have indicated that this chemosensitivity testing would be useful to improve the results of adjuvant chemotherapy, by increasing survivals in the sensitive group. The chemosensitivity testing is approved as “advanced clinical medicine” by the Japanese Ministry of Health, Welfare, and Labor at 11 institutes at present. While complete lymph-node dissection and chemosensitivity test-guided adjuvant chemotherapy has been reported to result in a survival benefit for patients with advanced gastrointestinal cancer, the clinical utility of the testing should be established by means of prospective, randomized clinical trials. Two pivotal clinical trials have been initiated to clarify the utility of chemosensitivity testing in the selection of the appropriate adjuvant cancer chemotherapy for gastric cancer.
Article PDF
Similar content being viewed by others
References
DL Schipper DJ Wagener (1996) ArticleTitleChemotherapy of gastric cancer Anticancer Drugs 7 137–49 Occurrence Handle8740718 Occurrence Handle1:CAS:528:DyaK28XjtF2ksbw%3D
JS Macdonald JJ Gohmann (1988) ArticleTitleChemotherapy of advanced gastric cancer: present status, future prospects Semin Oncol 15 IssueID3 Suppl 4 42–9 Occurrence Handle3293218 Occurrence Handle1:STN:280:BieB2sjptFI%3D
Y Sakata A Ohtsu N Horikoshi K Sugimachi Y Mitachi T Taguchi (1998) ArticleTitleLate phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients Eur J Cancer 34 1715–20 Occurrence Handle9893658 Occurrence Handle1:CAS:528:DyaK1cXntlShurw%3D Occurrence Handle10.1016/S0959-8049(98)00211-1
W Koizumi M Kurihara S Nakano K Hasegawa (2000) ArticleTitlePhase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group Oncology 58 191–7 Occurrence Handle10765119 Occurrence Handle1:CAS:528:DC%2BD3cXjvVeitr4%3D Occurrence Handle10.1159/000012099
W Koizumi S Tanabe K Saigenji A Ohtsu N Boku F Nagashima et al. (2003) ArticleTitlePhase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer Br J Cancer 89 2207–12 Occurrence Handle14676796 Occurrence Handle1:CAS:528:DC%2BD3sXpvVShtbc%3D Occurrence Handle10.1038/sj.bjc.6601413
T Kondo T Kubota T Tanimura H Yamaue S Akiyama Y Maehara et al. (2000) ArticleTitleCumulative results of chemosensitivity tests for antitumor agents in Japan Anticancer Res 20 2389–92
http://www.mhlw.go.jp/topics/0106/tp0601-1a.html
J Hermans JJ Bonenkamp MC Boon AMG Bunt S Ohyama M Sasako et al. (1993) ArticleTitleAdjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials J Clin Oncol 11 1441–7 Occurrence Handle8336183 Occurrence Handle1:STN:280:ByyA38bkvVE%3D
JP Pignon M Ducreux P Rougier (1994) ArticleTitleMeta-analysis of adjuvant chemotherapy in gastric cancer: a critical reappraisal J Clin Oncol 12 877–8 Occurrence Handle8151332 Occurrence Handle1:STN:280:ByuB3c7otV0%3D
T Nakajima K Ohta S Ohyama N Hamajima (1999) Meta-analysis of adjuvant chemotherapy trials for gastric cancer at the Cancer Institute Hospital T Nakajima T Yamaguchi (Eds) Multimodality therapy for gastric cancer Springer-Verlag Heidelberg Berlin New York Tokyo 27–31
CC Earle JA Maroun (1999) ArticleTitleAdjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomized trials Eur J Cancer 35 1059–64 Occurrence Handle10533448 Occurrence Handle1:STN:280:DC%2BD3c%2FgtlKnsw%3D%3D Occurrence Handle10.1016/S0959-8049(99)00076-3
E Mari I Floriani A Tinazzi A Buda M Belfiglio M Valentini et al. (2000) ArticleTitleEfficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente) Ann Oncol 11 837–43 Occurrence Handle10997811 Occurrence Handle1:STN:280:DC%2BD3cvks1SgtA%3D%3D Occurrence Handle10.1023/A:1008377101672
KG Janunger L Hafstroem P Nygren B Glimelius InstitutionalAuthorNameSBU-group. Swedish Council of Technology Assessment in Health Care (2001) ArticleTitleA systematic overview of chemotherapy effects in gastric cancer Acta Oncol 40 309–26 Occurrence Handle11441938 Occurrence Handle1:STN:280:DC%2BD3MzovVCisw%3D%3D Occurrence Handle10.1080/02841860151116385
I Panzini L Gianni PP Fattori D Tassinari M Imola P Fabbri et al. (2002) ArticleTitleAdjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses Tumori 88 21–7 Occurrence Handle12004845 Occurrence Handle1:CAS:528:DC%2BD38Xjt1ChtLo%3D
BibInstitutionalEditorNameJapanese Gastric Cancer Association (Eds) (2001) Guideline of gastric cancer therapy EditionNumber1st ed. Kanehara Tokyo
BibInstitutionalEditorNameJapanese Gastric Cancer Association (Eds) (2004) Guideline of gastric cancer therapy EditionNumber2nd ed. Kanehara Tokyo
JS Macdonald SR Smalley J Benedetti SA Hundahl NC Estes GN Stemmermann et al. (2001) ArticleTitleChemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725–30 Occurrence Handle11547741 Occurrence Handle1:STN:280:DC%2BD3Mvps1Cqug%3D%3D Occurrence Handle10.1056/NEJMoa010187
Kinoshita T, Nakajima T, Ohashi Y, National Surgical Adjuvant Study Group: Adjuvant chemotherapy with uracil-tegafur (UFT) for serosa negative advanced gastric cancer: results of a randomized trial by National Surgical Adjuvant Study of Gastric Cancer. Proc 41st ASCO, Abstract no. 4021; 2005. p. 313s
Cunningham D, Allum WH, Srtenning SP, Weeden S for the NCRI Upper GI Cancer Clinical Studies Group Perioperative chemotherapy in operable gastric and lower oesophageal cancer: final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971). Proc 41st ASCO Abstract no. 4001; 2005. p. 308s
Y Saikawa T Kubota T Furukawa A Suto M Watanabe K Kumai et al. (1994) ArticleTitleSingle-cell suspension assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer Jpn J Cancer Res 85 762–5 Occurrence Handle8071118 Occurrence Handle1:STN:280:ByuA2M%2FntFA%3D
T Mosmann (1983) ArticleTitleRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 55–63 Occurrence Handle6606682 Occurrence Handle1:STN:280:BiuD1cbgsFE%3D Occurrence Handle10.1016/0022-1759(83)90303-4
Y Shimoyama T Kubota M Watanabe K Ishibiki O Abe (1989) ArticleTitlePredictability of in vivo chemosensitivity by in vitro MTT assay with reference to clonogenic assay J Surg Oncol 41 12–8 Occurrence Handle2716329 Occurrence Handle1:CAS:528:DyaL1MXktFOjt7k%3D
A Suto T Kubota Y Shimoyama K Ishibiki O Abe (1989) ArticleTitleMTT assay with reference to the clinical effect of chemotherapy J Surg Oncol 42 28–32 Occurrence Handle2770307 Occurrence Handle1:STN:280:BiaA28zkvVw%3D
T Furukawa T Kubota A Suto T Takahara H Yamaguchi T Takeuchi et al. (1991) ArticleTitleClinical usefulness of chemosensitivity testing using the MTT assay J Surg Oncol 48 188–93 Occurrence Handle1943116 Occurrence Handle1:STN:280:By2D2cjks1Y%3D
T Furukawa T Kubota M Watanabe T Takahara H Yamaguchi T Takeuchi et al. (1992) ArticleTitleHigh in vitro-in vivo correlation of drug response using sponge-gel-supported three-dimensional histoculture and the MTT end point Int J Cancer 51 489–98 Occurrence Handle1592540 Occurrence Handle1:CAS:528:DyaK38XltVent7k%3D
T Furukawa T Kubota M Watanabe S Kase T Takahara H Yamaguchi et al. (1992) ArticleTitleChemosensitivity testing of clinical gastrointestinal cancers using histoculture and MTT endpoint Anticancer Res 12 1377–82 Occurrence Handle1444194 Occurrence Handle1:STN:280:ByyD2szmtVw%3D
T Furukawa T Kubota RM Hoffman (1995) ArticleTitleClinical applications of the histoculture drug response assay Clin Cancer Res 1 305–11 Occurrence Handle9815986 Occurrence Handle1:CAS:528:DyaK2sXhtVygu7k%3D
T Kubota N Sasano O Abe I Nakao E Kawamura T Saito et al. (1995) ArticleTitlePotential of the histoculture drug response assay to contribute to cancer patient survival Clin Cancer Res 1 1537–43 Occurrence Handle9815954 Occurrence Handle1:CAS:528:DyaK28XmvVWhsg%3D%3D
HJ Lenz CG Leichman KD Danenberg PV Danenberg S Groshen H Cohen et al. (1996) ArticleTitleThymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor of primary tumor response and overall survival J Clin Oncol 14 176–82 Occurrence Handle8558194 Occurrence Handle1:STN:280:BymC2c%2FivFM%3D
JJ Grau J Domingo-Domenrech V Morente M Pera JC Garcia-Valdecasas J Fuster et al. (2004) ArticleTitleLow thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant tegafur Oncology 66 226–33 Occurrence Handle15218314 Occurrence Handle1:CAS:528:DC%2BD2cXlt1Sltbs%3D Occurrence Handle10.1159/000077999
Y Ishikawa T Kubota Y Otani M Watanabe T Teramoto K Kumai et al. (2000) ArticleTitleDihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil Jpn J Cancer Res 91 105–12 Occurrence Handle10744051 Occurrence Handle1:CAS:528:DC%2BD3cXitVWlsr4%3D
F Toriumi T Kubota Y Saikawa M Yoshida Y Otani M Watanabe et al. (2004) ArticleTitleThymidylate synthetase genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric cancer Anticancer Res 24 2455–63 Occurrence Handle15330198 Occurrence Handle1:CAS:528:DC%2BD2cXot1Cgu7g%3D
M Terashima H Fujiwara A Takagane K Abe T Irinoda T Nakaya et al. (2003) ArticleTitlePrediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer Gastric Cancer 6 IssueIDSuppl 1 71–81 Occurrence Handle12775024 Occurrence Handle10.1007/s10120-003-0221-z
R Metzger CG Leichman KD Danenberg PV Danenberg HJ Lenz K Hayashi et al. (1998) ArticleTitleERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy J Clin Oncol 16 309–16 Occurrence Handle9440758 Occurrence Handle1:CAS:528:DyaK1cXmsFeruw%3D%3D
K Suganuma T Kubota Y Saikawa S Abe Y Otani T Furukawa et al. (2003) ArticleTitlePossible chemoresistance-related genes for gastric cancer detected by cDNA microarray Cancer Sci 94 355–9 Occurrence Handle12824904 Occurrence Handle1:CAS:528:DC%2BD3sXkslCns78%3D Occurrence Handle10.1111/j.1349-7006.2003.tb01446.x
K Fujita T Kubota SW Matsusaki Y Otani M Watanabe T Teramoto et al. (1998) ArticleTitleFurther evidence for the value of the chemosensitivity test in deciding appropriate chemotherapy for advanced gastric cancer Anticancer Res 18 1973–8 Occurrence Handle9677452 Occurrence Handle1:STN:280:DyaK1czkt1CitA%3D%3D
S Abe T Kubota SW Matsuzaki Y Otani M Watanabe T Teramoto et al. (1999) ArticleTitleChemosensitivity test is useful in evaluating the appropriate adjuvant cancer chemotherapy for stage III non-scirrhous gastric cancer Anticancer Res 19 4581–86 Occurrence Handle10650814 Occurrence Handle1:CAS:528:DC%2BD3cXns1Onsg%3D%3D
T Kubota T Egawa Y Otani T Furukawa Y Saikawa M Yoshida et al. (2003) ArticleTitleCancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages III/IV gastric cancers without peritoneal dissemination Anticancer Res 23 583–8 Occurrence Handle12680150 Occurrence Handle1:CAS:528:DC%2BD3sXivVyru7c%3D
DJ Samson J Seidenfeld K Ziegler N Aronson (2004) ArticleTitleChemotherapy sensitivity and resistance assays: a systematic review J Clin Oncol 22 3618–30 Occurrence Handle15289487 Occurrence Handle1:CAS:528:DC%2BD2cXpsVWrsrg%3D Occurrence Handle10.1200/JCO.2004.04.077
D Schrag HS Garewal HJ Burstein DJ Samson DD Von Hoff MR Somerfield (2004) ArticleTitleAmerican Society of Clinical Oncology Technology Assessment. Chemotherapy sensitivity and resistance assays J Clin Oncol 22 3631–8 Occurrence Handle15289488 Occurrence Handle1:CAS:528:DC%2BD2cXpsVWrsrY%3D Occurrence Handle10.1200/JCO.2004.05.065
Weisenthal LM, Nygren P. Current status of cell culture drug resistance testing (CCDRT). 2002. http://weisenthal.org/oncol_t.htm
S Paik S Shak G Tang C Kim J Baker M Cronin et al. (2004) ArticleTitleA multigene assay to predict recurrence to tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817–26 Occurrence Handle15591335 Occurrence Handle1:CAS:528:DC%2BD2MXhslymsw%3D%3D Occurrence Handle10.1056/NEJMoa041588
F Cappuzzo M Varella-Garcia H Shigematsu I Domenichini S Bartolini GL Ceresoli et al. (2005) ArticleTitleIncreased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients J Clin Oncol 23 5007–18 Occurrence Handle16051952 Occurrence Handle1:CAS:528:DC%2BD2MXpsFWmtLo%3D Occurrence Handle10.1200/JCO.2005.09.111
Kubota T. Chemosensitivity test for adjuvant cancer chemotherapy of gastric cancer (JACCRO GC-04). Igaku no Ayumi (J Clin Exp Med) 2006;217
Nomura E, Tanigawa N. JCOG clinical trial for evaluation of the utility of in vitro chemosensitivity test for cancer. Igaku no Ayumi (J Clin Exp Med) 2006;217
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kubota, T., Weisenthal, L. Chemotherapy sensitivity and resistance testing: to be “standard” or to be individualized, that is the question. Gastric Cancer 9, 82–87 (2006). https://doi.org/10.1007/s10120-006-0366-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10120-006-0366-7